Skip to main content
Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
Australia flag Australia · Delayed Price · Currency is AUD
33.09
+0.05 (0.15%)
At close: Dec 5, 2025

ASX:FPH Revenue

Fisher & Paykel Healthcare Corporation had revenue of 1.09B NZD in the half year ending September 30, 2025, with 35.44% growth. This brings the company's revenue in the last twelve months to 2.16B, up 14.18% year-over-year. In the fiscal year ending March 31, 2025, Fisher & Paykel Healthcare Corporation had annual revenue of 2.02B with 15.96% growth.

Revenue (ttm)
2.16B NZD
Revenue Growth
+14.18%
P/S Ratio
10.24
Revenue / Employee
290.09K NZD
Employees
7,440
Market Cap
19.38B AUD

Revenue Chart

* This company reports financials in NZD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20252.02B278.20M15.96%
Mar 31, 20241.74B161.70M10.23%
Mar 31, 20231.58B-100.60M-5.98%
Mar 31, 20221.68B-289.50M-14.69%
Mar 31, 20211.97B707.50M55.99%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 23.73B
Pro Medicus 212.98M
Cochlear 2.34B
Sonic Healthcare 9.65B
Ramsay Health Care 17.79B
Ansell 3.06B
Telix Pharmaceuticals 1.01B
Mesoblast 26.23M
Revenue Rankings

Fisher & Paykel Healthcare Corporation News

More News